Thirukkumaran CM - Search Results

1

Current Immunotherapeutic Strategies to Enhance Oncolytic Virotherapy.

Meyers DE, Wang AA, Thirukkumaran CM, Morris DG. Meyers DE, et al. Among authors: thirukkumaran cm. Front Oncol. 2017 Jun 6;7:114. doi: 10.3389/fonc.2017.00114. eCollection 2017. Front Oncol. 2017. PMID: 28634571 Free PMC article. Review.

2

Oncolytic virotherapy for multiple myeloma: past, present, and future.

Thirukkumaran CM, Morris DG. Thirukkumaran CM, et al. Bone Marrow Res. 2011;2011:632948. doi: 10.1155/2011/632948. Epub 2011 May 10. Bone Marrow Res. 2011. PMID: 22046569 Free PMC article.

3

Oncolytic virotherapy as an immunotherapeutic strategy for multiple myeloma.

Meyers DE, Thakur S, Thirukkumaran CM, Morris DG. Meyers DE, et al. Among authors: thirukkumaran cm. Blood Cancer J. 2017 Dec 5;7(12):640. doi: 10.1038/s41408-017-0020-0. Blood Cancer J. 2017. PMID: 29208938 Free PMC article. Review.

4

Oncolytic Reovirus and Immune Checkpoint Inhibition as a Novel Immunotherapeutic Strategy for Breast Cancer.

Mostafa AA, Meyers DE, Thirukkumaran CM, Liu PJ, Gratton K, Spurrell J, Shi Q, Thakur S, Morris DG. Mostafa AA, et al. Among authors: thirukkumaran cm. Cancers (Basel). 2018 Jun 15;10(6):205. doi: 10.3390/cancers10060205. Cancers (Basel). 2018. PMID: 29914097 Free PMC article.

5

Oncolytic Viral Therapy Using Reovirus.

Thirukkumaran C, Morris DG. Thirukkumaran C, et al. Methods Mol Biol. 2015;1317:187-223. doi: 10.1007/978-1-4939-2727-2_12. Methods Mol Biol. 2015. PMID: 26072409 Review.

6

Oncolytic viral therapy using reovirus.

Thirukkumaran C, Morris DG. Thirukkumaran C, et al. Methods Mol Biol. 2009;542:607-34. doi: 10.1007/978-1-59745-561-9_31. Methods Mol Biol. 2009. PMID: 19565924 Review.

7

Viral purging of haematological autografts: should we sneeze on the graft?

Thirukkumaran CM, Russell JA, Stewart DA, Morris DG. Thirukkumaran CM, et al. Bone Marrow Transplant. 2007 Jul;40(1):1-12. doi: 10.1038/sj.bmt.1705668. Epub 2007 Apr 23. Bone Marrow Transplant. 2007. PMID: 17450184 Review.

8

Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model.

Thirukkumaran CM, Shi ZQ, Nuovo GJ, Luider J, Kopciuk KA, Dong Y, Mostafa AA, Thakur S, Gratton K, Yang A, Chin AC, Coffey MC, Jimenez-Zepeda VH, Stewart D, Chesi M, Bergsagel PL, Morris D. Thirukkumaran CM, et al. Blood Adv. 2019 Mar 12;3(5):797-812. doi: 10.1182/bloodadvances.2018025593. Blood Adv. 2019. PMID: 30850386 Free PMC article.

9

Oncolytic viral therapy for prostate cancer: efficacy of reovirus as a biological therapeutic.

Thirukkumaran CM, Nodwell MJ, Hirasawa K, Shi ZQ, Diaz R, Luider J, Johnston RN, Forsyth PA, Magliocco AM, Lee P, Nishikawa S, Donnelly B, Coffey M, Trpkov K, Fonseca K, Spurrell J, Morris DG. Thirukkumaran CM, et al. Cancer Res. 2010 Mar 15;70(6):2435-44. doi: 10.1158/0008-5472.CAN-09-2408. Epub 2010 Mar 9. Cancer Res. 2010. PMID: 20215509

10

Reovirus as a viable therapeutic option for the treatment of multiple myeloma.

Thirukkumaran CM, Shi ZQ, Luider J, Kopciuk K, Gao H, Bahlis N, Neri P, Pho M, Stewart D, Mansoor A, Morris DG. Thirukkumaran CM, et al. Clin Cancer Res. 2012 Sep 15;18(18):4962-72. doi: 10.1158/1078-0432.CCR-11-3085. Epub 2012 Jul 3. Clin Cancer Res. 2012. PMID: 22761466

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page